Harvard Clinical Research Institute
Baim Institute for Clinical Research is a nonprofit academic research organization that designs, leads, and analyzes interventional and non-interventional clinical trials in drugs, devices, and diagnostics for pharmaceutical and medical device sponsors, academic health systems, and patient participants.
- Company typePrivate
- Founded2000
- HeadquartersBoston, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Harvard Clinical Research Institute does
Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute) is a nonprofit academic research organization headquartered in Boston that operates as an academic research organization (ARO) for clinical trials. The institute leads interventional and non-interventional studies across drugs, devices, and diagnostics, with a faculty-led model in which clinical trialists who are domain experts are matched to studies to provide scientific leadership from concept through analysis and implementation. Core service modules include collaborative trial design, study leadership, global site engagement across a community and academic institution network, biostatistics calibrated to withstand FDA scrutiny, and an independent Clinical Events Committee for event adjudication. The institute also operates Grand Rounds as an educational offering, maintains a publication archive of more than 5,500 publications spanning from 1980 to the present, and reports cumulative operational scale of 1,250 studies, 50+ FDA submissions, and 160,000+ participants enrolled.
The organization's business model is structured as a nonprofit ARO rather than a commercial CRO. Customer segments are Academic Health Systems, Industry Partners (pharmaceutical and medical device companies), and Patients enrolled in trials. The go-to-market is sales-led, executed through direct research collaborations rather than channel partners, with thought-leadership marketing via Grand Rounds, scientific conferences (CRT, ACC), newsletters, and the publication archive. Pricing is not publicly disclosed; revenue is generated through research collaborations and grants consistent with nonprofit academic research organization economics.
Recent strategic activity indicates therapeutic-area and geographic broadening. In June 2024, Baim entered a formal research collaboration with the GlomCon Foundation to advance kidney disease research, combining GlomCon's glomerular disease expertise and global expert network with Baim's clinical trial capabilities, and explicitly targeting real-world evidence studies, global registries, and randomized controlled trials in nephrology. The organization has also added a Senior VP of Strategic Initiatives and Business Development and claims a global footprint spanning continents, while still operating with a reported headcount of 51-100 employees and no disclosed funding rounds, parent company, or AI/ML capabilities.
Harvard Clinical Research Institute firmographics
Firmographics- Name
- Harvard Clinical Research Institute
- Legal name
- Baim Institute for Clinical Research
- Website
- https://baiminstitute.org
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Baim Institute for Clinical Research is a nonprofit academic research organization that designs, leads, and analyzes interventional and non-interventional clinical trials in drugs, devices, and diagnostics for pharmaceutical and medical device sponsors, academic health systems, and patient participants.
- Ownership category
- akta.pro rank
Where Harvard Clinical Research Institute is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Markets served
Harvard Clinical Research Institute business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Harvard Clinical Research Institute product offering
Product offeringCore offering
Harvard Clinical Research Institute, now operating as Baim Institute for Clinical Research, is a non-profit academic research organization (ARO) that designs, implements, and analyzes interventional and non-interventional clinical studies across drugs, devices, and diagnostics. The institute collaborates with academic health systems, industry partners, and patients to conduct high-quality clinical research, with faculty providing scientific leadership matched to therapeutic areas.
Product overview
The Baim Institute for Clinical Research is a nonprofit academic research organization (ARO) offering a unified portfolio of clinical trial services. The core offering consists of interventional and non-interventional studies across drugs, devices, and diagnostics, supported by dedicated service modules including Clinical Events Committee adjudication, biostatistics, trial design, and study leadership. Additional offerings include Grand Rounds educational presentations. The organization translates research results into practice and measures change, with a network of community and academic institutions.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trial Services
Quantifiable outcome
- 1,250+ studies conducted with 160K+ participants enrolled
- +1 more outcomes
Companies that use Harvard Clinical Research Institute
Customer profileSegments3 records
Ideal customer profiles2 records
Harvard Clinical Research Institute technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Harvard Clinical Research Institute partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- GlomCon FoundationmajorFormal research collaboration to advance kidney disease research. Combines GlomCon's expertise in glomerular diseases, global network of experts, and research platforms with Baim Institute's clinical trial design and management capabilities. Aims to support large real-world evidence studies, global registries, and randomized controlled trials in kidney diseases.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
Harvard Clinical Research Institute competitors and assessment
Company assessmentDirect peers
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-size CRO specializing in complex cardiovascular, neuroscience, and rare disease trials. Comparable therapeutic focus and science-driven operating model to Baim.
- Cleveland Clinic Coordinating Center for Clinical Research: Cleveland Clinic's in-house coordinating center manages multicenter cardiovascular and medical-device clinical trials with deep faculty involvement. Closely parallels Baim's university-affiliated ARO structure and cardiovascular concentration.
- Population Health Research Institute (PHRI): PHRI is a global academic research organization running large cardiovascular and population health trials, registries, and epidemiological studies. Comparable scale and nonprofit ARO operating model to Baim.
- Duke Clinical Research Institute (DCRI): DCRI is a nonprofit academic research organization within Duke that designs and manages multicenter clinical trials across multiple therapeutic areas, with a similarly strong focus on cardiovascular and outcomes research. It is the most directly comparable peer to Baim's nonprofit ARO model.
- TIMI Study Group: TIMI is an academic research organization at Brigham and Women's Hospital that designs and conducts large-scale cardiovascular clinical trials, providing biostatistics, study leadership, and regulatory-quality analysis. Direct overlap with Baim's cardiovascular ARO services.
Broad incumbents
- Parexel International: Parexel is a large global CRO/biometrics provider offering clinical trial design, biostatistics, and regulatory consulting to pharma sponsors. Competes with Baim on trial design and statistical analysis services.
- Medpace: Medpace is a mid-to-large full-service CRO known for therapeutically focused, scientifically led trial execution, particularly in cardiovascular and metabolic indications. Closest commercial analog to Baim's science-led model.
- ICON plc: ICON is a major global CRO providing full-service clinical development, biostatistics, and laboratory services to pharma and device sponsors. Broader portfolio than Baim but competes for the same commercial sponsor contracts.
- IQVIA: IQVIA is the world's largest commercial CRO offering full-service clinical trial design, biostatistics, and regulatory services across all therapeutic areas. Represents the at-scale commercial incumbent competing with Baim's academic-anchored offering.
- Charles River Laboratories: Charles River is a large CRO with broad preclinical and clinical research offerings, including biostatistics and clinical trial services. Overlaps with Baim on clinical research services for pharma and device sponsors.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Harvard Clinical Research Institute social profiles
Digital presenceHarvard Clinical Research Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Harvard Clinical Research Institute leadership team
Management profileNumber of profiles
Profiles1 record
Harvard Clinical Research Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Harvard Clinical Research Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Harvard Clinical Research Institute
What does Harvard Clinical Research Institute do?
Harvard Clinical Research Institute, now operating as Baim Institute for Clinical Research, is a non-profit academic research organization (ARO) that designs, implements, and analyzes interventional and non-interventional clinical studies across drugs, devices, and diagnostics. The institute collaborates with academic health systems, industry partners, and patients to conduct high-quality clinical research, with faculty providing scientific leadership matched to therapeutic areas.
Is Harvard Clinical Research Institute a public or private company?
Harvard Clinical Research Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Harvard Clinical Research Institute founded?
Harvard Clinical Research Institute was founded in 2000. It employs 51 to 100 people.
Where is Harvard Clinical Research Institute based?
Harvard Clinical Research Institute is headquartered in Boston, United States, in the North America region.
Who are Harvard Clinical Research Institute's main competitors?
Direct peers on record are Worldwide Clinical Trials, Cleveland Clinic Coordinating Center for Clinical Research, Population Health Research Institute (PHRI), Duke Clinical Research Institute (DCRI) and TIMI Study Group. Broad incumbents are Parexel International, Medpace, ICON plc, IQVIA and Charles River Laboratories.
Does Harvard Clinical Research Institute have an API?
No public API is recorded for Harvard Clinical Research Institute.